Positron Emission Tomography–Adapted Therapy in Bulky Stage I/II Classic Hodgkin Lymphoma: CALGB 50801 (Alliance)
      QxMD      Google Scholar   
Citation:
J Clin Oncol vol 41 (5) 1023-1034
Year:
2023
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Book Volume:
12
Parents:
3548   3597  
Children:
None
Program:
OGC
Primary Committee:
Lymphoma
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, U24CA196171, UG1CA233180, UG1CA233290, UG1CA233339, UG1CA189824  
Corr. Author:
 
Authors:
                           
Networks:
CAPITAL, LAPS-MA036, LAPS-MD017, LAPS-MN026, LAPS-MO011, LAPS-NY016, LAPS-OH007, NY018, NY141, VA009   
Study
CALGB-50801
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords:
ORIGINAL REPORTS, Hematologic Malignancy